Aberrant immunophenotypes in acute lymphoblastic leukemia

5Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

Abstract

Acute lymphoblastic leukemia (ALL) is the most prevalent hematologic neoplasia worldwide.To classify leukemia, we analyzed the immunophenotypic characteristics in the neoplastic cells obtained with antibodies by cell flow cytometry or immunohistochemistry. The aberrant immunophenotypes are antigen expression patterns that differ from the normal hematopoietic maturation process, which can include some different lineage antigens such as myeloid antigens in ALL or asynchronous expression of antigens. These aberrant immunophenotypes have been studied as prognostic factors and residual disease markers. In this review, some aspects of aberrant immunophenotypes are addressed, including definition, epidemiology, and potential uses.

Cite

CITATION STYLE

APA

Cuéllar-Mendoza, M. E., Chávez-Sánchez, F. R., Dorantes-Acosta, E., Arsuaga-Jiménez, B. M., & Zapata-Tarrés, M. (2020, November 1). Aberrant immunophenotypes in acute lymphoblastic leukemia. Boletin Medico Del Hospital Infantil de Mexico. Publicaciones Permanyer. https://doi.org/10.24875/BMHIM.20000171

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free